[go: up one dir, main page]

UA101297C2 - Замещенное циклическое соединение, способ его получения и его медицинское применение - Google Patents

Замещенное циклическое соединение, способ его получения и его медицинское применение

Info

Publication number
UA101297C2
UA101297C2 UAA200800830A UAA200800830A UA101297C2 UA 101297 C2 UA101297 C2 UA 101297C2 UA A200800830 A UAA200800830 A UA A200800830A UA A200800830 A UAA200800830 A UA A200800830A UA 101297 C2 UA101297 C2 UA 101297C2
Authority
UA
Ukraine
Prior art keywords
substituted cyclic
preparation
medical use
cyclic compound
formula
Prior art date
Application number
UAA200800830A
Other languages
English (en)
Ukrainian (uk)
Inventor
Файун Нан
Мингвей Вонг
Кайхонг Зхоу
На Ли
Квангксинг Вонг
Ксин Ксие
Квинг Лиу
Original Assignee
Шангхаи Инститьют Оф Матирия Медика, Чайниз Акедеми Оф Сайнс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шангхаи Инститьют Оф Матирия Медика, Чайниз Акедеми Оф Сайнс filed Critical Шангхаи Инститьют Оф Матирия Медика, Чайниз Акедеми Оф Сайнс
Publication of UA101297C2 publication Critical patent/UA101297C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/06—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Detergent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Данное изобретение обеспечивает замещенное циклическое соединение следующей общей формулы I или II:,способ его получения и его применения как регулятора рецептора глюкагоноподобного пептида 1 для предупреждения или лечения метаболических расстройств, включая, но не ограничиваясь, диабет, резистентность к инсулину и ожирение и т.п.
UAA200800830A 2005-06-24 2006-06-21 Замещенное циклическое соединение, способ его получения и его медицинское применение UA101297C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA200510027131XA CN1884278A (zh) 2005-06-24 2005-06-24 一类胰高血糖样肽－1受体调节剂、制备方法和用途
PCT/CN2006/001410 WO2006136101A1 (en) 2005-06-24 2006-06-21 Glucagon like peptide-1 receptor (glp-1r) regulators, preparation methods and uses

Publications (1)

Publication Number Publication Date
UA101297C2 true UA101297C2 (ru) 2013-03-25

Family

ID=37570110

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200800830A UA101297C2 (ru) 2005-06-24 2006-06-21 Замещенное циклическое соединение, способ его получения и его медицинское применение

Country Status (14)

Country Link
US (1) US8039492B2 (ru)
EP (1) EP1900721B1 (ru)
JP (1) JP4825266B2 (ru)
KR (1) KR100928475B1 (ru)
CN (1) CN1884278A (ru)
AU (1) AU2006261472B8 (ru)
BR (1) BRPI0613310A2 (ru)
CA (1) CA2613155C (ru)
IL (1) IL188199A (ru)
MX (1) MX2007016125A (ru)
RU (1) RU2378254C2 (ru)
UA (1) UA101297C2 (ru)
WO (1) WO2006136101A1 (ru)
ZA (1) ZA200800412B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1884278A (zh) 2005-06-24 2006-12-27 中国科学院上海药物研究所 一类胰高血糖样肽－1受体调节剂、制备方法和用途
CN101195586A (zh) * 2006-12-05 2008-06-11 中国科学院上海药物研究所 一类具有取代环戊烷结构的化合物、制备方法及其医学用途
CN101195613B (zh) * 2006-12-05 2012-08-08 中国科学院上海药物研究所 一类具有取代四元环结构的化合物及其医学用途
CN101195584A (zh) * 2006-12-05 2008-06-11 中国科学院上海药物研究所 一类具有取代环丙烷结构的化合物、制备方法及其医学用途
CN101195585A (zh) * 2006-12-05 2008-06-11 中国科学院上海药物研究所 一类具有取代环己烷结构的化合物、及其制备方法和医学用途
CN101195612B (zh) * 2006-12-05 2012-08-08 中国科学院上海药物研究所 一类具有取代环丁烷结构的化合物、及其制备方法和医学用途
CN101274927B (zh) * 2007-03-29 2011-04-27 中国科学院上海药物研究所 一类四元环状化合物的光化学反应制备方法及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR008789A1 (es) * 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
CN100453533C (zh) * 2003-12-12 2009-01-21 中国科学院上海药物研究所 一类胰高血糖样肽－1受体激动剂及其制备方法和用途
CN1884278A (zh) 2005-06-24 2006-12-27 中国科学院上海药物研究所 一类胰高血糖样肽－1受体调节剂、制备方法和用途

Also Published As

Publication number Publication date
WO2006136101A1 (en) 2006-12-28
US20100168183A1 (en) 2010-07-01
RU2008101661A (ru) 2009-07-27
IL188199A0 (en) 2008-03-20
EP1900721A4 (en) 2010-04-07
US8039492B2 (en) 2011-10-18
AU2006261472B8 (en) 2010-05-13
CA2613155C (en) 2011-06-07
ZA200800412B (en) 2008-10-29
BRPI0613310A2 (pt) 2010-12-28
MX2007016125A (es) 2008-03-06
EP1900721A1 (en) 2008-03-19
CN1884278A (zh) 2006-12-27
RU2378254C2 (ru) 2010-01-10
CA2613155A1 (en) 2006-12-28
AU2006261472B2 (en) 2010-04-22
AU2006261472A1 (en) 2006-12-28
KR100928475B1 (ko) 2009-11-25
JP4825266B2 (ja) 2011-11-30
JP2008543889A (ja) 2008-12-04
EP1900721B1 (en) 2013-05-08
KR20080021811A (ko) 2008-03-07
IL188199A (en) 2011-12-29

Similar Documents

Publication Publication Date Title
MX2009005935A (es) Compuestos biciclicos y su uso como anti-diabeticos.
MX2009007180A (es) Agonistas del receptor acoplado a la proteina g de la piperidina.
PL2114933T3 (pl) Piperydyny jako agoniści GPCR
TN2009000111A1 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
GB0812642D0 (en) Compounds
NO20080010L (no) GPCR-agonister
NZ611429A (en) Gpr120 receptor agonists and uses thereof
TN2010000125A1 (en) Substituted biphenyl gpr40 modulators
ATE557024T1 (de) Piperidinverbindungen als gpcr-agonisten
UA92355C2 (en) urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS
WO2007003961A3 (en) Gpcr agonists
MX2008010921A (es) Procesos para preparar productos de morfinan-6-ona con bajos niveles de compuestos de cetona alfa, beta-insaturados.
NO20084307L (no) Heterocykliske GPCR agonister
MY152114A (en) Novel pyrazole-4-n-alkoxycarboxamides as microbiocides
DE602007007473D1 (en) 11-beta-hydroxysteroid-dehydrogenase-1-hemmer
MX2009011358A (es) Derivados de pirimidinona y metodos para su uso.
MX2010009576A (es) Derivados de quinoxalinona como estimulantes de la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes.
MX2009009816A (es) Anticuerpos monoclonales para el tratamiento del cancer.
EA201170795A1 (ru) Антагонисты ccr2 группы 4-азетидинил-1-гетероарил-циклогексанола
MX2010001938A (es) Metodos para preparar compuestos basados en 4-fenil-6-(2,2,2-trifl uoro-1-feniletoxi)pirimidina.
TW200740814A (en) Compounds
MX2010009575A (es) Derivados de pirazinonas como estimulantes de la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes.
WO2010097576A8 (en) 1, 4-disubstituted piperidines as vasopressin receptor via antagonists
UA101297C2 (ru) Замещенное циклическое соединение, способ его получения и его медицинское применение
UA103191C2 (ru) Производные арилпиразинона как стимуляторы секреции инсулина, способ их получения (варианты) и их применение для лечения диабета